Comparing Objective and Subjective Physical Activity Assessments in Obese Patients

NCT06784804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2025-01-24

No results posted yet for this study

Summary

The goal of this observational study is to analyze the validity of self-reported physical activities in obese patients with psychosomatic disorders in a clinical setting. The main question aims to answer:

\- How valid are self-reported physical activity data (via the International Physical Activity Questionnaire, IPAQ-SF) compared to actigraphy-based objective measurements (using the SenseWear® armband, SWA)?

Between 2020 and 2022, 23 patients with obesity (21 anorexia nervosa, 2 bulimia nervosa) were recruited from an Austrian psychosomatic clinic. Receiving routine care, participants were additionally asked to

* wear the SWA for seven days in the clinic
* complete the IPAQ-SF for the same reference period on the first weekday after SWA wearing time

The study then statistically compared total physical activity, measured in so called metabolic equivalents (MET minutes per week), and sitting time (minutes per day) between the two methods to determine the accuracy of the self-reported data.

Conditions

  • Physical Activity
  • Anorexia Nervosa
  • Bulimia Nervosa
  • Obesity

Sponsors & Collaborators

  • Paracelsus Medical University

    lead OTHER

Principal Investigators

  • Hans-Peter Wiesinger, PhD · Paracelsus Medical University

  • Elmar Kaiser, Dr. med., Chief physician · Psychosomatic Clinic Eggenburg

  • Bettina Bannert, MA · Psychosomatic Clinic Eggenburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2022-03-30
Completion
2022-03-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06784804 on ClinicalTrials.gov